Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
European Journal of Endocrinology|June 25, 2020
Standardised patient education in adrenal insufficiency: a prospective multi-centre evaluationStephanie Burger-Stritt, Annemarie Eff, Marcus Quinkler, et al.American Journal of Medical Genetics. Part A|October 28, 2010
Marfan syndrome with neonatal progeroid syndrome-like lipodystrophy associated with a novel frameshift mutation at the 3' terminus of the FBN1-geneLuitgard M Graul-Neumann, Tina Kienitz, Peter N Robinson, et al.Journal of Clinical Medicine|October 14, 2023
Glucocorticoid Replacement for Adrenal Insufficiency and the Development of Non-Alcoholic Fatty Liver DiseaseGesine Meyer, Madeleine Gruendl, Irina Chifu, et al.Endocrinology, Diabetes & Metabolism Case Reports|November 26, 2015
Palliative treatment of uncontrollable hypercalcemia due to parathyrotoxicosis: denosumab as rescue therapyReiner Jumpertz von Schwartzenberg, Ulf Elbelt, Manfred Ventz, et al.The Journal of Clinical Endocrinology and Metabolism|October 16, 2019
Glucocorticoid Receptor Polymorphisms Influence Muscle Strength in Cushing's SyndromeLisa Marie Müller, Tina Kienitz, Timo Deutschbein, et al.European Journal of Endocrinology|March 30, 2023
Glucocorticoid receptor polymorphism BclI with increased glucocorticoid sensitivity has a positive influence on quality of life in endogenous Cushing's syndrome in remissionLara Feldkamp, Lisa Müller, Timo Deutschbein, et al.Journal of Endocrinological Investigation|July 8, 2026
Low work ability and high disability burden in Cushing's syndrome: a multicenter cohort studyAnnika Steinkogler, Stephanie Zopp, Kathrin Moser, et al.Frontiers in Endocrinology|March 19, 2026
Real world experience with [<sup>68</sup>Ga]PentixaFor PET/CT in Primary Aldosteronism using newly developed harmonized diagnostic criteriaLinus Hesse, Anna Herden, James MacFarlane, et al.Cancers|February 9, 2020
Effects of Germline CYP2W1*6 and CYP2B6*6 Single Nucleotide Polymorphisms on Mitotane Treatment in Adrenocortical Carcinoma: A Multicenter ENSAT StudyBarbara Altieri, Silviu Sbiera, Sabine Herterich, et al.Lancet (London, England)|February 25, 2024
Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trialEric Baudin, Bernard Goichot, Alfredo Berruti, et al.Pageof 4